Grégoire Serra combines a unique dual expertise in science and law, equipping him to skillfully navigate the complex intersection of research, innovation, and regulatory frameworks. With broad experience in pharmaceutical partnerships, technology transfer, and intellectual property, he plays a pivotal role in fostering strategic collaborations and accelerating the financing process to transform academic projects into clinical realities.

Dr. Stéphanie Ventéo holds a PhD in Neuroscience and serves as a Research Engineer at INSERM, where she leads her research group at the Institute for Neurosciences of Montpellier (INM). 

With over 25 years of experience, Dr. Ventéo has dedicated her career to advancing the understanding of the physiology and pathology of the somatosensory system, with a particular focus on chronic pain. Her extensive expertise and innovative research contribute to the development of groundbreaking solutions in pain management.

Dr. Jean-Philippe Annereau, PhD from École Polytechnique, brings over 20 years of expertise in the pharmaceutical industry, focusing on oncology and rare diseases. As the former CEO of Alexion R&D France and Medetia Pharmaceuticals, he has a proven track record in driving innovation.

At Dolinnov, Dr. Annereau serves as a key strategist, leveraging his deep industry knowledge to shape the company’s R&D direction and accelerate the development of transformative pain management solutions.

Pr. Céline Greco is the Head of the Pain and Palliative Medicine Department at Necker-Enfants Malades Hospital, one of France’s most renowned pediatric centers. She is also a member of the National Council for Child Protection (CNPE). As a physician-researcher, Pr. Greco is deeply committed to improving the quality of life for children, particularly those facing chronic pain or life-limiting conditions. Her expertise in pediatric pain management and palliative care combines clinical excellence with innovative research.

Neurologist, pain specialist, and professor of therapeutics at Ambroise Paré Hospital. She heads the Pain Evaluation and Treatment Center and is deputy director of INSERM U987, focusing on pain pathophysiology and clinical pharmacology. A leading expert in neuropathic pain, she has chaired international guidelines, authored 170+ peer-reviewed articles, and led numerous clinical trials. Her work has earned her prestigious awards, including the Chevalier de la Légion d’Honneur.

Dr. Alain Toledano is a prominent French oncologist and radiotherapist. He is the founder and president of the Institut Rafaël, France’s first integrative health center dedicated to post-cancer care. He serves as Medical Director of the Hartmann Institute and chairs the medical board of the Oncology Institute of Hauts-de-Seine. Dr. Toledano also leads the Research Chair in Integrative Health at the CNAM. A recognized expert in his field, he has held leadership roles in top medical institutions.

Philippe Barthélémy is a professor and Director of the ChemBioPharm team at the University of Bordeaux and the ARNA Laboratory (INSERM U1212/CNRS UMR 5320). He earned a PhD in Chemistry from the University of Montpellier II in 1993 and held positions at Emory, Duke, and Avignon before joining Bordeaux in 2005. With over 150 publications, 21 patents, and 100+ conference presentations, he is a leading expert in molecular and nano-chemistry.

With over 30 years of experience in experimental and regulatory toxicology, including recognition as a EUROTOX Toxicologist since 1997, François Hubert has served on national and international committees such as AFSSAPS, WHO, and the French Ministries of Health and Agriculture. A founding member of the National Committee on Animal Experimentation, they have contributed to toxicological evaluations for cosmetics, biocides, plant protection products, and fertilizers, ensuring regulatory compliance and product safety.